Almost all COVID-19 patients develop antibodies: WHO

Nearly 100 percent of COVID-19 patients develop antibodies regardless of the course of the disease, WHO’s Maria Van Kerkhove said Friday.

“What we understand is that 90 to 100 percent of people infected with the virus develop an antibody response, whether you have a mild infection or an asymptomatic infection up to a severe infection. And we are still learning how long that antibody response lasts. lasts, how strong it is, how it compares to immunity against another infection, and how long that lasts, ”said Van Kerkhove, epidemiology expert, during a virtual press conference.

Amid the continued spread of COVID-19, one of the most important tasks for epidemiologists is to determine the duration of immunity to the infection and the likelihood of reinfection.

WHO Director General Tedros Adhanom Ghebreyesus said Friday that the decisions of governments and individuals would be decisive in the coming days.

On Wednesday, the UK approved the Pfizer-BioNTech vaccine for emergency use, becoming the first country to do so. It gave the country a leap in mass vaccination against COVID-19.

“The pandemic has a long way to go. And decisions by leaders and citizens in the coming days will determine both the short-term course of the virus and when this pandemic will eventually end,” said Tedros.

According to Johns Hopkins University, there are 65,627,738 COVID-19 cases and 1,514,387 deaths. The United States remains the worst affected country with more than 14 million cases as different countries and government organizations around the world are at different stages in the production of the COVID-19 vaccine. (ANI)

Subscribe to Mint newsletters

* Please enter a valid email address

* Thank you for subscribing to our newsletter.

Source link